Redhill Biopharma Ltd

Redhill Biopharma’s chief business officer holds 305 million shares and RSUs, showing insider confidence amid a steep share decline – a bullish signal for investors.

Redhill Biopharma’s CEO keeps his stake steady, signalling confidence amid a volatile share price and a deep‑discounted market cap. Insider stability hints at long‑term optimism as the company pursues late‑stage trials.